Protocol No.: RDEA594-301; A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects with Gout

Project: Other project

StatusFinished
Effective start/end date6/20/126/19/14

Funding

  • Ardea Biosciences: $4,580.00